Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand
Aims/hypothesis: Our aims were to compare osteoclastic activity between patients with acute Charcot's osteoarthropathy and diabetic and healthy controls, and to determine the effect of the receptor activator of nuclear factor-kappaB ligand (RANKL) and its decoy receptor osteoprotegerin (OPG). M...
Main Authors: | Mabilleau, G, Petrova, N, Edmonds, M, Sabokbar, A |
---|---|
Other Authors: | European Association for the Study of Diabetes (EASD) |
Format: | Journal article |
Language: | English |
Published: |
Springer-Verlag
2008
|
Subjects: |
Similar Items
-
Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand.
by: Mabilleau, G, et al.
Published: (2008) -
Hyperactivity of osteoclast precursors in acute charcot osteoarthropathy
by: Mabilleau, G, et al.
Published: (2008) -
RANKL plays an important role as activator of osteoclastic bone resorption in acute Charcot osteoarthropathy
by: Petrova, N, et al.
Published: (2007) -
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
by: Mabilleau, G, et al.
Published: (2009) -
Increased percentage of CD14+monocytes in acute Charcot osteoarthropathy
by: Petrova, N, et al.
Published: (2008)